
Neo-Xprita Pharmaceuticals Private Limited
Founded in 2012 and headquartered in Maharashtra, India.
Founded in 2012 and headquartered in Maharashtra, India.
Nagpur, Maharashtra, India
+91-XXXXXXXXXX
U24233MH2012PTC232075
232075
Private Limited Indian Non-Government Company
12 Jun 2012
-
-
Unlisted
Roc Mumbai
Name | Designation | Appointment Date | Status |
---|---|---|---|
Ratindra Sarkar ![]() | Director | 12-Jun-2012 | Current |
Abhijeet Nagrale ![]() | Director | 12-Jun-2012 | Current |
Enhance accessibility to Neo-Xprita Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Neo-Xprita Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Abhijeet Nagrale is a mutual person
Abhijeet Nagrale is a mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Neo-Xprita Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Neo-Xprita Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neo-Xprita Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Abhijeet Yashwant Nagrale was appointed as a Director was appointed as a Director on 12 Jun 2012 & has been associated with this company since 12 years 9 months .
Ratindra Kumar Ravindra Kumar Sarkar was appointed as a Director was appointed as a Director on 12 Jun 2012 & has been associated with this company since 12 years 9 months .
Neo-Xprita Pharmaceuticals Private Limited was registered on 12 Jun 2012 with Roc Mumbai & aged 12 years 9 months as per MCA records.
Neo-Xprita Pharmaceuticals Private Limited was incorporated on 12 Jun 2012.
The authorized share capital of Neo-Xprita Pharmaceuticals Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.
Currently 2 directors are associated with Neo-Xprita Pharmaceuticals Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Neo-Xprita Pharmaceuticals Private Limited is Plot No.277 At Yadav Nagar Binaki Layout, India, Nagpur, Maharashtra, 440017.
The corporate identification number (CIN) of Neo-Xprita Pharmaceuticals Private Limited is U24233MH2012PTC232075 and the company number is 232075 as per Ministry of Corporate Affairs (MCA).